Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsReceivables - Net
Ratios

Traws Pharma (TRAW) Accumulated Depreciation & Amortization (2016 - 2024)

Traws Pharma (TRAW) has disclosed Accumulated Depreciation & Amortization for 13 consecutive years, with $72000.0 as the latest value for Q3 2024.

  • On a quarterly basis, Accumulated Depreciation & Amortization changed N/A to $72000.0 in Q3 2024 year-over-year; TTM through Sep 2024 was $72000.0, a N/A change, with the full-year FY2023 number at $62000.0, up 34.78% from a year prior.
  • Accumulated Depreciation & Amortization was $72000.0 for Q3 2024 at Traws Pharma, up from $66000.0 in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $2.2 million in Q3 2020 to a low of $18000.0 in Q4 2020.
  • A 5-year average of $227916.7 and a median of $47500.0 in 2022 define the central range for Accumulated Depreciation & Amortization.
  • Peak YoY movement for Accumulated Depreciation & Amortization: crashed 99.19% in 2020, then skyrocketed 77.78% in 2021.
  • Traws Pharma's Accumulated Depreciation & Amortization stood at $18000.0 in 2020, then skyrocketed by 77.78% to $32000.0 in 2021, then skyrocketed by 43.75% to $46000.0 in 2022, then surged by 34.78% to $62000.0 in 2023, then rose by 16.13% to $72000.0 in 2024.
  • Per Business Quant, the three most recent readings for TRAW's Accumulated Depreciation & Amortization are $72000.0 (Q3 2024), $66000.0 (Q1 2024), and $62000.0 (Q4 2023).